Etoposide, pirarubicin and cisplatin (ETP) combined therapy of inoperable head and neck cancer
Kawakami, T.; Watanabe, S.; Ogawara, T.; Akagi, S.; Tamura, S.; Koide, I.; Ogawa, A.; Takiguchi, S.; Masuda, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(5): 669-672
1993
ISSN/ISBN: 0385-0684 PMID: 8470928 Document Number: 410403
Document emailed within 1 workday
Related Documents
González-Larriba, J.L.; Garcia Carbonero, I.; Sastre Valera, J.; Perez Segura, P.; Diaz-Rubio, E. 1997: Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer Oncology 11(9 Suppl 10: 90-97Pantusa, M.; Balli, M.; De Maria, D.; Mattioli, R.; Balli, R.; Galetti, G. 1978: Initial results of combined chemo-radiotherapy treatment in inoperable cancer of the head and neck (proceedings) La Radiologia Medica 64(7-8): 937-938
Liu, S.; Lin, Y.; Tang, S.; Yang, H.; Liang, C. 2001: IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma Hua Xi Kou Qiang Yi Xue Za Zhi 19(3): 191-193
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Yoshida, M.; Suzuki, S.; Enokida, T.; Ishiki, H.; Ichida, Y.; Saitoh, S.; Endo, K.; Izumi, K.; Tahara, M. 2014: Evaluation of aprepitant as a prophylactic antiemetic in the Cisplatin split regimen combined with radiation for patients with head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(9): 1103-1106
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Manegold, C. 1998: Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer Seminars in Oncology 25(4 Suppl 9: 18-22
Berthelsen, A.; Nielsen, E.S.; Rygård, J. 1986: Advanced head and neck carcinoma treated with combined cisplatin and fluorouracil infusions Ugeskrift for Laeger 148(33): 2080-2082
Cullen, M.H.; Latief, T.N.; Spooner, D.; Mould, J.J.; Chetiyawaraana, A.D. 1985: Cisplatin, etoposide, and radiotherapy in regional inoperable squamous cell carcinoma of the bronchus Seminars in Oncology 12(1 Suppl 2: 14-16
Shoji, S.; Miyakita, H.; Shima, M.; Usui, Y.; Nagata, Y.; Uchida, T.; Terachi, T. 2006: Acute myocardial infarction during combined chemotherapy with bleomycin, etoposide and cisplatin for testicular cancer Hinyokika Kiyo. Acta Urologica Japonica 52(9): 723-726
Hato, N.; Yumoto, E.; Hyodo, M.; Hinohira, Y.; Kawamura, T.; Fujii, T. 1998: Radiotherapy combined with daily administration of low-dose cisplatin for squamous cell carcinomas of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(10): 1533-1537
Nishino, H.; Abe, K.; Ishikawa, K.; Kanazawa, T.; Tanaka, H.; Miyata, M.; Kitamura, K.; Morita, M. 1999: Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(11): 1617-1621
Tu, G.-y.; Xu, Z.-g.; Liu, S.-y. 2009: From head and neck surgery to head and neck oncology: the disciplinary guarantee for comprehensive cancer therapy Zhonghua Zhong Liu Za Zhi 31(11): 877-879
Lund, B.; Hansen, O.P.; Hansen, H.H.; Hansen, M. 1992: Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer Seminars in Oncology 19(1 Suppl 1: 26-29
Tokunaga, A.; Onda, M.; Mizutani, T.; Miyamoto, M.; Nomura, T.; Hayashi, H.; Kiyama, T.; Umehara, M.; Nishi, K.; Andoh, T. 1989: Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(12): 3713-3718
Tanaka, S.; Morikawa, Y. 1991: Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(6): 1039-1041
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Taylor, S.G.; Murthy, A.K.; Showel, J.L.; Caldarelli, D.D.; Hutchinson, J.C.; Holinger, L.D.; Kramer, T.; Kiel, K. 1985: Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy Cancer Treatment Reports 69(9): 933-939
Mencoboni, M.; Rebella, L.; Tredici, S.; Ghio, R.; Scarpati, D.; Bavazzano, M.; Jankowska, B.; Delle Piane, M. 2005: Concurrent chemo-radiotherapy with taxotere and cisplatin in head and neck cancer: a feasibility study Anticancer Research 25(6c): 4451-4454
Merlano, M.; Tatarek, R.; Grimaldi, A.; Margarino, G.; Rosso, R. 1985: Phase I-Ii trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule Cancer Treatment Reports 69(9): 961-964